WIPO logo
Mobile | Deutsch | Español | Français | 日本語 | 한국어 | Português | Русский | 中文 | العربية |
PATENTSCOPE

Search International and National Patent Collections
World Intellectual Property Organization
Search
 
Browse
 
Translate
 
Options
 
News
 
Login
 
Help
 
Machine translation
1. (WO2015119183) LIQUID DRUG CONTAINING ACTIVE VITAMIN D3 OR DERIVATIVE THEREOF
Latest bibliographic data on file with the International Bureau   

Pub. No.:    WO/2015/119183    International Application No.:    PCT/JP2015/053190
Publication Date: 13.08.2015 International Filing Date: 05.02.2015
IPC:
A61K 31/592 (2006.01), A61K 9/08 (2006.01), A61K 47/10 (2006.01), A61K 47/18 (2006.01), A61K 47/26 (2006.01), A61M 5/28 (2006.01), A61M 5/31 (2006.01), A61M 5/315 (2006.01), A61P 3/02 (2006.01)
Applicants: KYOWA HAKKO KIRIN CO., LTD. [JP/JP]; 1-6-1, Ohtemachi, Chiyoda-ku, Tokyo 1008185 (JP)
Inventors: TOMODA, Yutaka; (JP).
TSUKAMOTO, Kyoko; (JP)
Priority Data:
2014-020090 05.02.2014 JP
Title (EN) LIQUID DRUG CONTAINING ACTIVE VITAMIN D3 OR DERIVATIVE THEREOF
(FR) MÉDICAMENT LIQUIDE CONTENANT DE LA VITAMINE D3 ACTIVE OU UN DÉRIVÉ DE CELLE-CI
(JA) 活性型ビタミンD3またはその誘導体を含有する液剤
Abstract: front page image
(EN)The present invention provides a liquid drug that contains active vitamin D3 or a derivative thereof, said liquid drug containing: active vitamin D3 or a derivative thereof in which the occurrence of changes, such as cloudiness, in a solution inside a container is prevented, and a decrease in the content of active vitamin D3 or a derivative thereof is prevented; and at least one selected from among sugar alcohols, amino sugars, and basic amino acids.
(FR)La présente invention concerne un médicament liquide qui contient de la vitamine D3 active ou un dérivé de celle-ci, ledit médicament liquide contenant : de la vitamine D3 active ou un dérivé de celle-ci, la survenue de changements, tels qu'une turbidité, dans une solution à l'intérieur d'un récipient étant empêchée, et une diminution de la teneur en vitamine D3 active ou en un dérivé de celle-ci étant empêchée ; et au moins un élément sélectionné parmi des polyols, des sucres aminés, et des acides aminés basiques.
(JA) 本発明は、容器内における白濁等の溶液の変化の発生や、活性型ビタミンD3またはその誘導体含量の低下が防止された、活性型ビタミンD3またはその誘導体と、糖アルコール、アミノ糖および塩基性アミノ酸から選ばれる1以上とを含有する、活性型ビタミンD3またはその誘導体含有液剤等を提供する。
Designated States: AE, AG, AL, AM, AO, AT, AU, AZ, BA, BB, BG, BH, BN, BR, BW, BY, BZ, CA, CH, CL, CN, CO, CR, CU, CZ, DE, DK, DM, DO, DZ, EC, EE, EG, ES, FI, GB, GD, GE, GH, GM, GT, HN, HR, HU, ID, IL, IN, IR, IS, JP, KE, KG, KN, KP, KR, KZ, LA, LC, LK, LR, LS, LU, LY, MA, MD, ME, MG, MK, MN, MW, MX, MY, MZ, NA, NG, NI, NO, NZ, OM, PA, PE, PG, PH, PL, PT, QA, RO, RS, RU, RW, SA, SC, SD, SE, SG, SK, SL, SM, ST, SV, SY, TH, TJ, TM, TN, TR, TT, TZ, UA, UG, US, UZ, VC, VN, ZA, ZM, ZW.
African Regional Intellectual Property Organization (BW, GH, GM, KE, LR, LS, MW, MZ, NA, RW, SD, SL, ST, SZ, TZ, UG, ZM, ZW)
Eurasian Patent Organization (AM, AZ, BY, KG, KZ, RU, TJ, TM)
European Patent Office (AL, AT, BE, BG, CH, CY, CZ, DE, DK, EE, ES, FI, FR, GB, GR, HR, HU, IE, IS, IT, LT, LU, LV, MC, MK, MT, NL, NO, PL, PT, RO, RS, SE, SI, SK, SM, TR)
African Intellectual Property Organization (BF, BJ, CF, CG, CI, CM, GA, GN, GQ, GW, KM, ML, MR, NE, SN, TD, TG).
Publication Language: Japanese (JA)
Filing Language: Japanese (JA)